首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors.
【24h】

Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors.

机译:4,5-二苯恶唑酮衍生物在合成选择性COX-2抑制剂过程中的合成和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 3-unsubstituted/substituted-4,5-diphenyl-2-oxo-3H-1,3-oxazole derivatives were prepared as selective cyclooxygenase-2 (COX-2) inhibitors. Among the synthesized compounds, 4-(4-phenyl-3-methyl-2-oxo-3H-1,3-oxazol-5-yl)benzensulfonamide (compound 6) showed selective COX-2 inhibition with a selectivity index of >50 (IC(50)COX-1=>100 microm, IC(50)COX-2=2 microm) in purified enzyme (PE) assay. Compound 6 also exhibited selective COX-2 inhibition in human whole blood assay. Molecular docking studies showed that 6 can be docked into the COX-2 binding site thus providing the molecular basis for its activity.
机译:制备了一系列3-未取代/取代的4,5-二苯基-2-氧代-3H-1,3-恶唑衍生物作为选择性环加氧酶-2(COX-2)抑制剂。在合成的化合物中,4-(4-苯基-3-甲基-2-氧代-3H-1,3-恶唑-5-基)苯磺酰胺(化合物6)表现出选择性COX-2抑制作用,选择性指数> 50 (IC(50)COX-1 => 100微米,IC(50)COX-2 = 2微米)在纯化酶(PE)分析中。化合物6在人全血测定中也表现出选择性的COX-2抑制作用。分子对接研究表明6可以对接到COX-2结合位点,从而为其活性提供分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号